PHARMA & DRUGS
(for more information, click title to open PDF file)
Nagoya University is currently seeking companies interested in commercializing a novel pharmaceutical composition for treatment or prevention of liver cancer.
Nagoya University is seeking companies interested in commercializing a novel therapeutic strategy for B cell malignant lymphocyte resistant to Rituximab.
Nagoya University is actively seeking companies interested in commercializing a novel method to inhibit and digest an aggregating protein such as an androgen receptor (AR) having an abnormally extended polyglutamine chain.
Baclofen, a GABAB agonist, has been used to treat muscle stiffness in patients with multiple sclerosis or cerebral palsy without apparent side effects.
The technology provides a neuronal cell death inhibitor comprising a compound having an inhibitory activity on the production and/or release of glutamate in activated microglia.
Obesity has attracted significant attention as a serious public-health problem.
Researchers at Nagoya University have found that a component of Ginger, 6-Shogaol, disrupts microtubule polymerization and inhibits the proliferation of cancer cells.
Researchers at Nagoya University have identified a novel agent which will overcome the treatment failure of drug resistant cancers.
Researchers at Nagoya University have identified that an archaeal proteasome is useful for digesting an aggregating protein such as mutant superoxide dismutase 1 (SOD1) or an androgen receptor (AR) having an abnormally extended polyglutamine chain in human cells.
Researchers at Nagoya University have developed a novel method to produce mesenchymal stem cells.
Researchers at Nagoya University have developed an effective method to collect and produce large amounts of multipotential stem cells (MSCs) derived from human adipose tissues.
D-serine functions as a co-agonist of the N-methylic-D-aspartic acid (NMDA) receptor in the mammalian brain.
Polyamines are growth factor having a very simple structure and which interact with certain acidic high-molecular materials to exhibit various physiological activities.
The Epstein-Barr virus (EBV) is a member of the herpes virus family, which includes herpes simplex virus 1 and 2, and is one of the most common viruses in humans.
Researchers at Nagoya University have invented a new drug delivery system using a novel electrode.
Researchers at Nagoya University and Meijo University have synthesized a novel neurotrophic factor (NGF)-enhancing compound, which shows memory recovery effects on aged mice and senescence-accelerated mice (SAM).
Researchers at Nagoya University have developed a novel medical use of adipose-derived mesenchymal stem cells (ADSCs) for neurogenic bladder therapy.
A damaged central nervous system (CNS) usually does not recover again.
With the progress of an increasingly aging society, the number of patients with Alzheimer's disease continues to increase.
Researchers at Nagoya University reported for the first time in the world that the thyroid transaction factor-1 (TTF-1) gene is involved in peripheral lung differentiation and contributes as a master regulatory factor of cell differentiation.
Blood coagulation disorder (also called bleeding disorder) produces prolonged or excessive bleeding.
Non-steroidal anti-inflammatory drugs such as Aspirin and Ibuprofen have been used for a long time in the treatment of inflammatory arthritis, although they have gastrointestinal and renal adverse effects.
Myocardial infarction (MI) is a major cause of sudden cardiac death in industrial countries.
Atmospheric plasma technology has been recently collecting more attention.